
Cambridge-based UK antibody development firm Kymab has appointed Anne Hyland as its chief financial officer. Hyland takes to the firm …
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ

